GLP-1 agonists

Specialty Pharma CDMO OneSource Recently Launched

OneSource Specialty Pharma, a newly incorporated CDMO, formed from the merger of three CDMO businesses within the Strides Group. The company has a 30-year track record and specializes in biologics, drug-device combinations, and soft gelatin capsules.

CordenPharma Invests €900 Million in Peptide Platform Expansion

CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.

Eli Lilly Broadens Diabetes Offer